FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
The Food and Drug Administration announced on Friday an approval of a new self- and caregiver-administered nose spray against ...
AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...
Today’s approval means that FluMist is the first pharmacy-prescribed influenza vaccine that does not need to be given by a ...
Through a third-party pharmacy, people interested in the self or caregiver option will complete a screening and eligibility ...
Astra said the FDA-required studies "showed that 100% of intended users administered a full dose. "In addition, data show that efficacy, immunogenicity and adverse events with self-administration of ...
FluMist is a nasally-administered influenza vaccine that is indicated for active immunization to prevent influenza disease in individuals 2 to 49 years of age.
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...
The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a ...
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...
The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, ...
The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a ...